US$ 27.39
glp 1 new indications Molecules and Emerging for GLP-1 Medicines Color coding GLP-1s & Beyond: Understanding Incretin
Description
Which makes me wonder whether the real platform opportunity is not around prescribing the drug, but around what happens once the biological shortcut runs its course and behaviour has to catch up

Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality

Weight regain and appetite rebound are well-documented

Kyeremanteng also notes that GLP-1s can blunt appetite, so you cant rely on food alone to meet your electrolyte needs

This is not guideline-based and may reduce efficacy
Injectable medications should always involve a licensed provider and a licensed pharmacy
